نتائج البحث - Foroogh Alborzi Avanaki

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
  1. 1
    Prevalence of Non-Celiac Gluten Sensitivity in Patients with Refractory Functional Dyspepsia: a Randomized Double-blind Placebo Controlled Trial

    Prevalence of Non-Celiac Gluten Sensitivity in Patients with Refractory Functional Dyspepsia: a Randomized Double-blind Placebo Controlled Trial حسب Bijan Shahbazkhani, Mohammad Mahdi Fanaeian, M J Farahvash, Najmeh Aletaha, Foroogh Alborzi Avanaki, Luca Elli, Amirhossein Shahbazkhani, Jayran Zebardast, Mohammad Rostami‐Nejad

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Evaluating the Safety and Efficacy of MSCs-derived Exosomes for Treatment of Resistant Perianal Fistula in IBD patients; Clinical Trial Phase I

    Evaluating the Safety and Efficacy of MSCs-derived Exosomes for Treatment of Resistant Perianal Fistula in IBD patients; Clinical Trial Phase I حسب Hojjatollah Nazari, Asieh Heirani, Masoud Soleimani, Reza Akbari Asbagh, Behnam Behboudi, Mohammad Sadegh Fazeli, Mojgan Rahimi, Mohammad Reza Keramati, Amir Keshvari, Alireza Kazemeini, Foroogh Alborzi Avanaki, Seyed Mohsen Ahmadi Tafti

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Pré-impressão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Evaluating the Safety and Efficacy of MSCs-derived Exosomes for Treatment of Refractory Perianal Fistula in IBD patients; Clinical Trial Phase I

    Evaluating the Safety and Efficacy of MSCs-derived Exosomes for Treatment of Refractory Perianal Fistula in IBD patients; Clinical Trial Phase I حسب Hojjatollah Nazari, Asieh Heirani, Masoud Soleimani, Reza Akbari Asbagh, Alireza Hadizadeh, Behnam Behboudi, Mohammad Sadegh Fazeli, Mojgan Rahimi, Mohammad Reza Keramati, Amir Keshvari, Alireza Kazemeini, Foroogh Alborzi Avanaki, Seyed Mohsen Ahmadi Tafti

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Pré-impressão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients: clinical trial phase I

    Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients: clinical trial phase I حسب Hojjatollah Nazari, Foroogh Alborzi Avanaki, Asieh Heirani‐Tabasi, Alireza Hadizadeh, Reza Akbari Asbagh, Behnam Behboudi, Mohammad Sadegh Fazeli, Mojgan Rahimi, Mohammad Reza Keramati, Amir Keshvari, Alireza Kazemeini, Masoud Soleimani, Seyed Mohsen Ahmadi Tafti

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Inflammatory bowel disease evolution in the past two decades: a chronological multinational study

    Inflammatory bowel disease evolution in the past two decades: a chronological multinational study حسب Pezhman Alavine­jad, Seyed Jalal Hashemi, Nitin Behl, Ahmad Hormati, Abubakr Elbasuny, Naser Ebrahimi Daryani, Mehdi Pezeshgi Modarres, Masoud Arshadzadeh, Samira Panahande, Hang Viet Dao, Aya Mohammed Mahros, Abazar Parsi, Hazhir Javaherizadeh, Ata Ur Rehman, Katarzyna M. Pawlak, Mitra Ahmadi, Mohammed Hussien Ahmed, Farnaz Farsi, Mohammad Mahdi Arefi, Afreen Quadri, Quang Trung Tran, Foroogh Alborzi Avanaki, Seyed Mohammad Amin Alavi, Bahman Cheraghian, Elmira Ramezani, M Gouda, Babak Saadati, Ahmed Alam Quadri, Rahim Hirani, M Maher, Elsayed Ghoneem

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: